NARISSA ROQUE BREGER
WINNETKA, IL
Browse related groups: IL Amgen Inc. All categories
General Payments — all program years on this page
$187.98
- Category: General Payments
- Program years: PY2023–2024
- Record count: 10
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $173.97 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $173.97 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $58.15 | 3 |
| Lilly USA, LLC | $27.81 | 2 |
| ABBVIE INC. | $25.22 | 1 |
| Acerta Pharma LLC | $22.09 | 1 |
| Paratek Pharmaceuticals, Inc. | $20.91 | 1 |
| Merck Sharp & Dohme Corporation | $19.79 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1104327294 | AstraZeneca Pharmaceuticals LP | $22.09 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1106819041 | ABBVIE INC. | $25.22 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1113925662 | Paratek Pharmaceuticals, Inc. | $20.91 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117209646 | Amgen Inc. | $19.21 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117209648 | Amgen Inc. | $24.07 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117209650 | Amgen Inc. | $14.87 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135896770 | Lilly USA, LLC | $13.10 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135909875 | Lilly USA, LLC | $14.71 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141949813 | Merck Sharp & Dohme LLC | $19.79 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.